Alamar Biosciences, Inc. · NASDAQ:ALMR
Nicholas Naclerio reported a 9.60% stake in Alamar Biosciences, Inc. (Schedule 13D)
Event Apr 20, 2026 · Filed Apr 23, 2026
Nicholas Naclerio reported a 9.60% stake in Alamar Biosciences, Inc., 6,363,612 shares, with active intent on Apr 20, 2026. Filed Apr 23, 2026 (Schedule 13D).
- Stake
- 9.60%
- Shares
- 6,363,612
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Illumina Innovation Fund II GP, L.L.C. | 8.80% | 5,856,536 |
| Illumina Innovation Fund II, L.P. | 8.80% | 5,856,536 |
| Illumina Innovation Fund III GP, L.L.C. | 0.80% | 507,076 |
| Illumina Innovation Fund III, L.P. | 0.80% | 507,076 |
| Nicholas Naclerio | 9.60% | 6,363,612 |
Source
Related
- Alamar Biosciences, Inc.
- Nicholas Naclerio
- Alamar Biosciences, Inc. shareholders
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 19, 2026
- Form 4 · Brottem John L. · Sep 16, 2026
- Form 4 · Ragusa Robert P · Sep 3, 2026
- Schedule 13G · Yuling Luo · Aug 13, 2026
- Schedule 13G · Qiming Corporate GP VI, Ltd. · Aug 11, 2026